Skip to content

MENTANA DX: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MENTANA DX

BE 0786.290.908
NACE 72.101, Research and development on biotechnology
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
-€31,505
2024 · -€35,144+€3,639
Equity
€228,548
2024 · €260,053-€31,505
Cash
€3,274
2024 · €266,686-€263,411
Balance sheet total
€229,998
2024 · €266,686-€36,688

Largest movements

2024 to 2025
Assets
  • Cash -€263,411

    down €263,411 (-98.8%), from €266,686 to €3,274

    mainly Receivables within one year (-€224,915) and Net result for the year (-€31,505)

  • Receivables within one year +€224,915

    up €224,915 (+36,871,318%), from €1 to €224,916

Equity and liabilities
  • Profit (loss) carried forward -€31,505

    down €31,505 (-78.9%), from -€39,947 to -€71,452

  • Trade debts -€5,183

    down €5,183 (-78.1%), from €6,633 to €1,450

Income statement
  • Financial income +€2,484

    new in 2025: €2,484

  • Gross operating margin +€1,650

    up €1,650 (+4.7%), from -€34,876 to -€33,226

  • Other operating charges +€403

    up €403 (+168%), from €241 to €644

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 -€35,144
Gross operating margin +€1,650
Other operating charges -€403
Financial income +€2,484
Financial charges -€91
Result 2025 -€31,505
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€263,411
Investment €0
Financing €0
Cash 2024 €266,686
Net result for the year -€31,505
Receivables within one year -€224,915
Deferred charges and accrued income -€1,808
Trade debts -€5,183
Cash 2025 €3,274
takes cash out
Every line side by side 24 lines
Line Code 2024 2025 Change %
Total assets 20/58 €266,686 €229,998 -€36,688 -13.8%
Current assets 29/58 €266,686 €229,998 -€36,688 -13.8%
Amounts receivable within one year 40/41 €1 €224,916 +€224,915 +36,871,318%
Other amounts receivable 41 €1 €224,916 +€224,915 +36,871,318%
Cash at bank and in hand 54/58 €266,686 €3,274 -€263,411 -98.8%
Deferred charges and accrued income 490/1 - €1,808 +€1,808
Total equity and liabilities 10/49 €266,686 €229,998 -€36,688 -13.8%
Equity 10/15 €260,053 €228,548 -€31,505 -12.1%
Contributions 10/11 €300,000 €300,000 = 0.0%
Profit (loss) carried forward 14 -€39,947 -€71,452 -€31,505 -78.9%
Amounts payable 17/49 €6,633 €1,450 -€5,183 -78.1%
Amounts payable within one year 42/48 €6,633 €1,450 -€5,183 -78.1%
Trade debts 44 €6,633 €1,450 -€5,183 -78.1%
Suppliers 440/4 €6,633 €1,450 -€5,183 -78.1%
Other operating charges 640/8 €241 €644 +€403 +168%
Gross operating margin 9900 -€34,876 -€33,226 +€1,650 +4.7%
Operating profit (loss) 9901 -€35,116 -€33,869 +€1,247 +3.6%
Financial income 75/76B - €2,484 +€2,484
Recurring financial income 75 - €2,484 +€2,484
Financial charges 65/66B €28 €119 +€91 +328%
Recurring financial charges 65 €28 €119 +€91 +328%
Profit (loss) for the period before taxes 9903 -€35,144 -€31,505 +€3,639 +10.4%
Profit (loss) for the period 9904 -€35,144 -€31,505 +€3,639 +10.4%
Profit (loss) for the period to be appropriated 9905 -€35,144 -€31,505 +€3,639 +10.4%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 October 2026 via checked.be.